Exploratory study for SGLT2 inhibitor -Glucose lowering action, influences of dietary habits/exercise habits on therapeutic effects, and treatment satisfactio
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000016993
- Lead Sponsor
- Kanagawa Physicians Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Not provided
1) Received SGLT 2 inhibitors within 6 months before providing consent 2) Type 1 diabetes 3) Severe ketosis, diabetic coma or precoma within 6 months 4) Treatment with Insulin preparation and/or GLP -1 receptor agonist 5) Severe infection, been pre-/post-surgery, and serious trauma 6) Severe hepatic dysfunction 7) Moderate or severe renal dysfunction 8) Hypersensitivity to any ingredient of the study drug 9) Urinary tract infection and genital infection 10) Contraindications to undergoing oral hypoglycemic agents (DPP-4 inhibitor, Sulfonylurea, Metformin etc.) 11) Enrolled in other current clinical trials 12) Pregnancy, nursing and possibility of pregnant or plan to pregnant 13) Considered as inadequate by the principal investigator or investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method